Jonathan Kagan

Publications

1. NLRP11 promotes non-canonical inflammasome activation in human macrophages by enhancing caspase-4 recognition of cytosolic lipopolysaccharide. bioRxiv. 2026 Feb 04. View Abstract
2. MAVS oligomerization drives a faster and more efficient antiviral signaling activation at peroxisomes compared to mitochondria. FEBS J. 2026 Apr; 293(7):2086-2097. View Abstract
3. Towards a molecular and structural definition of cell death. Nat Struct Mol Biol. 2025 Oct; 32(10):1854-1858. View Abstract
4. An NLRP3-stimulatory adjuvant improves the immunogenicity of influenza virus vaccines in mice and non-human primates. mBio. 2025 Oct 08; 16(10):e0234325. View Abstract
5. Oxidized phospholipid damage signals as modulators of immunity. Open Biol. 2025 Jul; 15(7):240391. View Abstract
6. Regulation of inflammatory responses by pH-dependent transcriptional condensates. Cell. 2025 Oct 02; 188(20):5632-5652.e25. View Abstract
7. Control of Inflammatory Response by Tissue Microenvironment. bioRxiv. 2025 May 30. View Abstract
8. LPS binding caspase activation and recruitment domains (CARDs) are bipartite lipid binding modules. Sci Adv. 2025 Mar 07; 11(10):eadt9027. View Abstract
9. ARIES domains: functional signaling units of type I interferon responses. FEBS J. 2025 Nov; 292(22):5888-5898. View Abstract
10. Pyroptotic cell corpses are crowned with F-actin-rich filopodia that engage CLEC9A signaling in incoming dendritic cells. Nat Immunol. 2025 Jan; 26(1):42-52. View Abstract
11. A pan-family screen of nuclear receptors in immunocytes reveals ligand-dependent inflammasome control. Immunity. 2024 12 10; 57(12):2737-2754.e12. View Abstract
12. LPS binding caspase activation and recruitment domains (CARDs) are bipartite lipid binding modules. bioRxiv. 2024 Oct 11. View Abstract
13. Molecular definition of the endogenous Toll-like receptor signalling pathways. Nature. 2024 Jul; 631(8021):635-644. View Abstract
14. pLxIS-containing domains are biochemically flexible regulators of interferons and metabolism. Mol Cell. 2024 Jul 11; 84(13):2436-2454.e10. View Abstract
15. Waking the sleeping giant: Single-stranded DNA binds Schlafen 11 to initiate innate immune responses. Sci Immunol. 2024 06 14; 9(96):eadp4474. View Abstract
16. Correction of age-associated defects in dendritic cells enables CD4+ T cells to eradicate tumors. Cell. 2024 Jul 25; 187(15):3888-3903.e18. View Abstract
17. Structural transitions enable interleukin-18 maturation and signaling. Immunity. 2024 07 09; 57(7):1533-1548.e10. View Abstract
18. Strategies of bacterial detection by inflammasomes. Cell Chem Biol. 2024 May 16; 31(5):835-850. View Abstract
19. The palmitoylation of gasdermin D directs its membrane translocation and pore formation during pyroptosis. Sci Immunol. 2024 04 12; 9(94):eadn1452. View Abstract
20. ROS-dependent S-palmitoylation activates cleaved and intact gasdermin D. Nature. 2024 Jun; 630(8016):437-446. View Abstract
21. Candida albicans extracellular vesicles trigger type I IFN signalling via cGAS and STING. Nat Microbiol. 2024 Jan; 9(1):95-107. View Abstract
22. Publisher Correction: Structural insights into cytokine cleavage by inflammatory caspase-4. Nature. 2024 Jan; 625(7995):E17. View Abstract
23. Structural insights into cytokine cleavage by inflammatory caspase-4. Nature. 2023 12; 624(7991):451-459. View Abstract
24. mRNAs encoding self-DNA reactive cGAS enhance the immunogenicity of lipid nanoparticle vaccines. mBio. 2023 12 19; 14(6):e0250623. View Abstract
25. Gasdermin D permeabilization of mitochondrial inner and outer membranes accelerates and enhances pyroptosis. Immunity. 2023 11 14; 56(11):2523-2541.e8. View Abstract
26. Innate immunity decreases pathogen diversity during infection. Proc Natl Acad Sci U S A. 2023 10 03; 120(40):e2314237120. View Abstract
27. Targeting innate immune pathways for cancer immunotherapy. Immunity. 2023 10 10; 56(10):2206-2217. View Abstract
28. Inflammasomes as regulators of non-infectious disease. Semin Immunol. 2023 09; 69:101815. View Abstract
29. Ultrasound-responsive low-dose doxorubicin liposomes trigger mitochondrial DNA release and activate cGAS-STING-mediated antitumour immunity. Nat Commun. 2023 06 30; 14(1):3877. View Abstract
30. Molecular mechanisms of gasdermin D pore-forming activity. Nat Immunol. 2023 07; 24(7):1064-1075. View Abstract
31. Beyond natural biology: rewiring cellular networks to study innate immunity. Curr Opin Immunol. 2023 08; 83:102349. View Abstract
32. Cold Spring Harbor Laboratory 2022: emerging insights and viewpoints in immunology. Trends Immunol. 2023 04; 44(4):248-255. View Abstract
33. ROS-dependent palmitoylation is an obligate licensing modification for GSDMD pore formation. bioRxiv. 2023 03 07. View Abstract
34. Infection infidelities drive innate immunity. Science. 2023 01 27; 379(6630):333-335. View Abstract
35. Species-specific self-DNA detection mechanisms by mammalian cyclic GMP-AMP synthases. Sci Immunol. 2023 01 20; 8(79):eabp9765. View Abstract
36. Gasdermin D pore-forming activity is redox-sensitive. Cell Rep. 2023 01 31; 42(1):112008. View Abstract
37. Excess lipids on endosomes dictates NLRP3 localization and inflammasome activation. Nat Immunol. 2023 01; 24(1):3-4. View Abstract
38. Glycine inhibits NINJ1 membrane clustering to suppress plasma membrane rupture in cell death. Elife. 2022 12 05; 11. View Abstract
39. Protocol to purify recombinant inflammatory caspases and assess their catalytic activity in vitro. STAR Protoc. 2022 12 16; 3(4):101848. View Abstract
40. Lipopolysaccharide detection by the innate immune system may be an uncommon defence strategy used in nature. Open Biol. 2022 10; 12(10):220146. View Abstract
41. Diverse Control Mechanisms of the Interleukin-1 Cytokine Family. Front Cell Dev Biol. 2022; 10:910983. View Abstract
42. Control of innate immunity by the cGAS-STING pathway. Immunol Cell Biol. 2022 07; 100(6):409-423. View Abstract
43. Human Cytomegalovirus vMIA Inhibits MAVS Oligomerization at Peroxisomes in an MFF-Dependent Manner. Front Cell Dev Biol. 2022; 10:871977. View Abstract
44. Depletion of the apical endosome in response to viruses and bacterial toxins provides cell-autonomous host defense at mucosal surfaces. Cell Host Microbe. 2022 02 09; 30(2):216-231.e5. View Abstract
45. Gasdermin Pore Forming Activities that Promote Inflammation from Living and Dead Cells. J Mol Biol. 2022 02 28; 434(4):167427. View Abstract
46. Heterologous Expression and Assembly of Human TLR Signaling Components in Saccharomyces cerevisiae. Biomolecules. 2021 Nov 22; 11(11). View Abstract
47. Cytosolic detection of phagosomal bacteria-Mechanisms underlying PAMP exodus from the phagosome into the cytosol. Mol Microbiol. 2021 12; 116(6):1420-1432. View Abstract
48. Emerging roles of peroxisomes in viral infections. Trends Cell Biol. 2022 02; 32(2):124-139. View Abstract
49. NIAID ClinRegs-a Public Database of Country Clinical Research Regulatory and Ethics Requirements: Design and Utilization Analysis. Clin Infect Dis. 2021 10 05; 73(7):1296-1301. View Abstract
50. TBK1 and IKKe act like an OFF switch to limit NLRP3 inflammasome pathway activation. Proc Natl Acad Sci U S A. 2021 09 21; 118(38). View Abstract
51. Innate immune detection of lipid oxidation as a threat assessment strategy. Nat Rev Immunol. 2022 05; 22(5):322-330. View Abstract
52. Strategy management in collaborative clinical research partnerships. Contemp Clin Trials Commun. 2021 Dec; 24:100833. View Abstract
53. Evolution-inspired redesign of the LPS receptor caspase-4 into an interleukin-1ß converting enzyme. Sci Immunol. 2021 08 10; 6(62). View Abstract
54. Control of gasdermin D oligomerization and pyroptosis by the Ragulator-Rag-mTORC1 pathway. Cell. 2021 08 19; 184(17):4495-4511.e19. View Abstract
55. Matrix lumican endocytosed by immune cells controls receptor ligand trafficking to promote TLR4 and restrict TLR9 in sepsis. Proc Natl Acad Sci U S A. 2021 07 06; 118(27). View Abstract
56. NLRP3 inflammasomes that induce antitumor immunity. Trends Immunol. 2021 07; 42(7):575-589. View Abstract
57. Virus-mediated inactivation of anti-apoptotic Bcl-2 family members promotes Gasdermin-E-dependent pyroptosis in barrier epithelial cells. Immunity. 2021 07 13; 54(7):1447-1462.e5. View Abstract
58. Interferon-Independent Restriction of RNA Virus Entry and Replication by a Class of Damage-Associated Molecular Patterns. mBio. 2021 04 13; 12(2). View Abstract
59. Deep-sea microbes as tools to refine the rules of innate immune pattern recognition. Sci Immunol. 2021 03 12; 6(57). View Abstract
60. Inflammasomes within Hyperactive Murine Dendritic Cells Stimulate Long-Lived T Cell-Mediated Anti-tumor Immunity. Cell Rep. 2020 11 17; 33(7):108381. View Abstract
61. Mitochondrial Reactive Oxygen Species Participate in Signaling Triggered by Heme in Macrophages and upon Hemolysis. J Immunol. 2020 11 15; 205(10):2795-2805. View Abstract
62. HDAC6 mediates an aggresome-like mechanism for NLRP3 and pyrin inflammasome activation. Science. 2020 09 18; 369(6510). View Abstract
63. Toll-like Receptors and the Control of Immunity. Cell. 2020 03 19; 180(6):1044-1066. View Abstract
64. Asymmetric distribution of TLR3 leads to a polarized immune response in human intestinal epithelial cells. Nat Microbiol. 2020 01; 5(1):181-191. View Abstract
65. A randomized evaluation of on-site monitoring nested in a multinational randomized trial. Clin Trials. 2020 02; 17(1):3-14. View Abstract
66. Gasdermin D activity in inflammation and host defense. Sci Immunol. 2019 09 06; 4(39). View Abstract
67. Inflammasomes: Threat-Assessment Organelles of the Innate Immune System. Immunity. 2019 10 15; 51(4):609-624. View Abstract
68. Patterns, dynamics and consequences of microplastic ingestion by the temperate coral, Astrangia poculata. Proc Biol Sci. 2019 06 26; 286(1905):20190726. View Abstract
69. Lipids that directly regulate innate immune signal transduction. Innate Immun. 2020 01; 26(1):4-14. View Abstract
70. Host-Encoded Sensors of Bacteria: Our Windows into the Microbial World. Microbiol Spectr. 2019 05; 7(3). View Abstract
71. Modular Architecture of the STING C-Terminal Tail Allows Interferon and NF-?B Signaling Adaptation. Cell Rep. 2019 04 23; 27(4):1165-1175.e5. View Abstract
72. Innate Immune Signaling Organelles Display Natural and Programmable Signaling Flexibility. Cell. 2019 04 04; 177(2):384-398.e11. View Abstract
73. Phosphoinositide Interactions Position cGAS at the Plasma Membrane to Ensure Efficient Distinction between Self- and Viral DNA. Cell. 2019 03 07; 176(6):1432-1446.e11. View Abstract
74. Defying Death: The (W)hole Truth about the Fate of GSDMD Pores. Immunity. 2019 01 15; 50(1):15-17. View Abstract
75. Vector Immunity and Evolutionary Ecology: The Harmonious Dissonance. Trends Immunol. 2018 11; 39(11):862-873. View Abstract
76. The Fly Way of Antiviral Resistance and Disease Tolerance. Adv Immunol. 2018; 140:59-93. View Abstract
77. An Antiviral Branch of the IL-1 Signaling Pathway Restricts Immune-Evasive Virus Replication. Mol Cell. 2018 09 06; 71(5):825-840.e6. View Abstract
78. Retraction Notice to: The Unfolded Protein Response Element IRE1a Senses Bacterial Proteins Invading the ER to Activate RIG-I and Innate Immune Signaling. Cell Host Microbe. 2018 04 11; 23(4):571. View Abstract
79. STING-dependent translation inhibition restricts RNA virus replication. Proc Natl Acad Sci U S A. 2018 02 27; 115(9):E2058-E2067. View Abstract
80. Biochemical Isolation of the Myddosome from Murine Macrophages. Methods Mol Biol. 2018; 1714:79-95. View Abstract
81. The Pore-Forming Protein Gasdermin D Regulates Interleukin-1 Secretion from Living Macrophages. Immunity. 2018 01 16; 48(1):35-44.e6. View Abstract
82. By Capturing Inflammatory Lipids Released from Dying Cells, the Receptor CD14 Induces Inflammasome-Dependent Phagocyte Hyperactivation. Immunity. 2017 10 17; 47(4):697-709.e3. View Abstract
83. How Inflammasomes Inform Adaptive Immunity. J Mol Biol. 2018 01 19; 430(2):217-237. View Abstract
84. Type III IFNs Are Commonly Induced by Bacteria-Sensing TLRs and Reinforce Epithelial Barriers during Infection. J Immunol. 2017 11 01; 199(9):3270-3279. View Abstract
85. Environmental Stress Causes Lethal Neuro-Trauma during Asymptomatic Viral Infections. Cell Host Microbe. 2017 Jul 12; 22(1):48-60.e5. View Abstract
86. Apoptosis and Necroptosis as Host Defense Strategies to Prevent Viral Infection. Trends Cell Biol. 2017 11; 27(11):800-809. View Abstract
87. Innate Immune Receptors as Competitive Determinants of Cell Fate. Mol Cell. 2017 Jun 15; 66(6):750-760. View Abstract
88. Lipopolysaccharide Detection across the Kingdoms of Life. Trends Immunol. 2017 10; 38(10):696-704. View Abstract
89. Multi-receptor detection of individual bacterial products by the innate immune system. Nat Rev Immunol. 2017 Jun; 17(6):376-390. View Abstract
90. Activation and pathogenic manipulation of the sensors of the innate immune system. Microbes Infect. 2017 Apr - May; 19(4-5):229-237. View Abstract
91. Microbe-inducible trafficking pathways that control Toll-like receptor signaling. Traffic. 2017 01; 18(1):6-17. View Abstract
92. Early innate immune responses to bacterial LPS. Curr Opin Immunol. 2017 Feb; 44:14-19. View Abstract
93. Biomarkers of Environmental Enteropathy, Inflammation, Stunting, and Impaired Growth in Children in Northeast Brazil. PLoS One. 2016; 11(9):e0158772. View Abstract
94. A one-protein signaling pathway in the innate immune system. Sci Immunol. 2016 Aug 19; 1(2):eaah6184. View Abstract
95. Editorial overview: Emerging concepts in host-virus interactions. Curr Opin Microbiol. 2016 08; 32:xii-xiii. View Abstract
96. Control of the innate immune response by the mevalonate pathway. Nat Immunol. 2016 08; 17(8):922-9. View Abstract
97. Peroxisomes are platforms for cytomegalovirus' evasion from the cellular immune response. Sci Rep. 2016 05 16; 6:26028. View Abstract
98. Assessing Clinical Research Capacity in Vietnam: A Framework for Strengthening Capability for Clinical Trials in Developing Countries. Public Health Rep. 2016 May-Jun; 131(3):396-403. View Abstract
99. An endogenous caspase-11 ligand elicits interleukin-1 release from living dendritic cells. Science. 2016 Jun 03; 352(6290):1232-6. View Abstract
100. Hepatitis C virus NS3-4A inhibits the peroxisomal MAVS-dependent antiviral signalling response. J Cell Mol Med. 2016 Apr; 20(4):750-7. View Abstract
101. A Single Bacterial Immune Evasion Strategy Dismantles Both MyD88 and TRIF Signaling Pathways Downstream of TLR4. Cell Host Microbe. 2015 Dec 09; 18(6):682-93. View Abstract
102. Mechanisms of Toll-like Receptor 4 Endocytosis Reveal a Common Immune-Evasion Strategy Used by Pathogenic and Commensal Bacteria. Immunity. 2015 Nov 17; 43(5):909-22. View Abstract
103. PRRs are watching you: Localization of innate sensing and signaling regulators. Virology. 2015 May; 479-480:104-9. View Abstract
104. The unique regulation and functions of type III interferons in antiviral immunity. Curr Opin Virol. 2015 Jun; 12:47-52. View Abstract
105. Microbial strategies for antagonizing Toll-like-receptor signal transduction. Curr Opin Immunol. 2015 Feb; 32:61-70. View Abstract
106. Innate immune pattern recognition: a cell biological perspective. Annu Rev Immunol. 2015; 33:257-90. View Abstract
107. ACT2 peer-driven intervention increases enrollment into HIV/AIDS medical studies among African Americans/Blacks and Hispanics: A cluster randomized controlled trial. AIDS Behav. 2014 Dec; 18(12):2409-22. View Abstract
108. Emerging principles governing signal transduction by pattern-recognition receptors. Cold Spring Harb Perspect Biol. 2014 Nov 13; 7(3):a016253. View Abstract
109. SMOCs: supramolecular organizing centres that control innate immunity. Nat Rev Immunol. 2014 12; 14(12):821-6. View Abstract
110. Common mechanisms activate plant guard receptors and TLR4. Trends Immunol. 2014 Oct; 35(10):454-6. View Abstract
111. Late endosomal trafficking of alternative serotype adenovirus vaccine vectors augments antiviral innate immunity. J Virol. 2014 Sep; 88(18):10354-63. View Abstract
112. Diverse intracellular pathogens activate type III interferon expression from peroxisomes. Nat Immunol. 2014 Aug; 15(8):717-26. View Abstract
113. Endosomes as platforms for NOD-like receptor signaling. Cell Host Microbe. 2014 May 14; 15(5):523-5. View Abstract
114. A cross-disciplinary perspective on the innate immune responses to bacterial lipopolysaccharide. Mol Cell. 2014 Apr 24; 54(2):212-23. View Abstract
115. A promiscuous lipid-binding protein diversifies the subcellular sites of toll-like receptor signal transduction. Cell. 2014 Feb 13; 156(4):705-16. View Abstract
116. A bicistronic MAVS transcript highlights a class of truncated variants in antiviral immunity. Cell. 2014 Feb 13; 156(4):800-11. View Abstract
117. Finding a needle in a haystack of needles - a productive hunt for interferon stimulated genes with antiviral activity. Immunol Cell Biol. 2014 Mar; 92(3):205-7. View Abstract
118. Increasing value and reducing waste in biomedical research regulation and management. Lancet. 2014 Jan 11; 383(9912):176-85. View Abstract
119. Immunology. Sensing endotoxins from within. Science. 2013 Sep 13; 341(6151):1184-5. View Abstract
120. NLRP3 inflammasome activation: CD36 serves double duty. Nat Immunol. 2013 Aug; 14(8):772-4. View Abstract
121. Recognition for an innate explorer. Cell. 2013 Jul 18; 154(2):261-4. View Abstract
122. The unfolded protein response element IRE1a senses bacterial proteins invading the ER to activate RIG-I and innate immune signaling. Cell Host Microbe. 2013 May 15; 13(5):558-569. View Abstract
123. Peroxisomes and the antiviral responses of mammalian cells. Subcell Biochem. 2013; 69:67-75. View Abstract
124. Intracellular pathogen detection by RIG-I-like receptors. Adv Immunol. 2013; 117:99-125. View Abstract
125. Signaling organelles of the innate immune system. Cell. 2012 Dec 07; 151(6):1168-78. View Abstract
126. Polymorphisms in toll-like receptor 4 underlie susceptibility to tumor induction by the mouse polyomavirus. J Virol. 2012 Nov; 86(21):11541-7. View Abstract
127. Defining the subcellular sites of innate immune signal transduction. Trends Immunol. 2012 Sep; 33(9):442-8. View Abstract
128. Phagosome as the organelle linking innate and adaptive immunity. Traffic. 2012 Aug; 13(8):1053-61. View Abstract
129. Phosphoinositide binding by the Toll adaptor dMyD88 controls antibacterial responses in Drosophila. Immunity. 2012 Apr 20; 36(4):612-22. View Abstract
130. CD14 controls the LPS-induced endocytosis of Toll-like receptor 4. Cell. 2011 Nov 11; 147(4):868-80. View Abstract
131. A phenotype of early infancy predicts reactivity of the amygdala in male adults. Mol Psychiatry. 2012 Oct; 17(10):1042-50. View Abstract
132. The IAP-antagonist ARTS initiates caspase activation upstream of cytochrome C and SMAC/Diablo. Cell Death Differ. 2012 Feb; 19(2):356-68. View Abstract
133. MyD88-dependent TLR1/2 signals educate dendritic cells with gut-specific imprinting properties. J Immunol. 2011 Jul 01; 187(1):141-50. View Abstract
134. Deciphering the function of nucleic acid sensing TLRs one regulatory step at a time. Front Biosci (Landmark Ed). 2011 06 01; 16(6):2060-8. View Abstract
135. Regulation of lipopolysaccharide-induced translation of tumor necrosis factor-alpha by the toll-like receptor 4 adaptor protein TRAM. J Innate Immun. 2011; 3(5):437-46. View Abstract
136. Interferon ß is associated with type 1 interferon-inducible gene expression in dermatomyositis. Ann Rheum Dis. 2011 May; 70(5):831-6. View Abstract
137. Recycling endosomes and TLR signaling--the Rab11 GTPase leads the way. Immunity. 2010 Oct 29; 33(4):578-80. View Abstract
138. Peroxisomes are signaling platforms for antiviral innate immunity. Cell. 2010 May 14; 141(4):668-81. View Abstract
139. "Complementing" toll signaling. Sci Signal. 2010 May 04; 3(120):pe15. View Abstract
140. Selective modulation of TLR4-activated inflammatory responses by altered iron homeostasis in mice. J Clin Invest. 2009 Nov; 119(11):3322-8. View Abstract
141. A cell biological view of Toll-like receptor function: regulation through compartmentalization. Nat Rev Immunol. 2009 Aug; 9(8):535-42. View Abstract
142. TRAM couples endocytosis of Toll-like receptor 4 to the induction of interferon-beta. Nat Immunol. 2008 Apr; 9(4):361-8. View Abstract
143. Phosphoinositide-mediated adaptor recruitment controls Toll-like receptor signaling. Cell. 2006 Jun 02; 125(5):943-55. View Abstract
144. Intracellular localization of Toll-like receptor 9 prevents recognition of self DNA but facilitates access to viral DNA. Nat Immunol. 2006 Jan; 7(1):49-56. View Abstract
145. Association of selected phenotypic markers of lymphocyte activation and differentiation with perinatal human immunodeficiency virus transmission and infant infection. Clin Diagn Lab Immunol. 2005 May; 12(5):622-31. View Abstract
146. Serum neopterin, an immune activation marker, independently predicts disease progression in advanced HIV-1 infection. Clin Infect Dis. 2005 Mar 15; 40(6):853-8. View Abstract
147. Analysis of Rab1 recruitment to vacuoles containing Legionella pneumophila. Methods Enzymol. 2005; 403:71-81. View Abstract
148. A C-terminal translocation signal required for Dot/Icm-dependent delivery of the Legionella RalF protein to host cells. Proc Natl Acad Sci U S A. 2005 Jan 18; 102(3):826-31. View Abstract
149. Immunophenotypic markers and antiretroviral therapy (IMART): T cell activation and maturation help predict treatment response. J Infect Dis. 2004 May 15; 189(10):1811-20. View Abstract
150. Legionella subvert the functions of Rab1 and Sec22b to create a replicative organelle. J Exp Med. 2004 May 03; 199(9):1201-11. View Abstract
151. Microtubule motors control membrane dynamics of Salmonella-containing vacuoles. J Cell Sci. 2004 Mar 01; 117(Pt 7):1033-45. View Abstract
152. Can immune markers predict subsequent discordance between immunologic and virologic responses to antiretroviral therapy? Adult AIDS Clinical Trials Group. Clin Infect Dis. 2003 Aug 15; 37(4):551-8. View Abstract
153. Cellular and Molecular Aspects of Legionella pneumophila transport to the endoplasmic reticulum. 2003. View Abstract
154. Legionella phagosomes intercept vesicular traffic from endoplasmic reticulum exit sites. Nat Cell Biol. 2002 Dec; 4(12):945-54. View Abstract
155. A bacterial guanine nucleotide exchange factor activates ARF on Legionella phagosomes. Science. 2002 Jan 25; 295(5555):679-82. View Abstract
156. Further evidence of association between behavioral inhibition and social anxiety in children. Am J Psychiatry. 2001 Oct; 158(10):1673-9. View Abstract
157. Efficacy of a mixed amphetamine salts compound in adults with attention-deficit/hyperactivity disorder. Arch Gen Psychiatry. 2001 Aug; 58(8):775-82. View Abstract
158. Biological constraint, cultural variety, and psychological structures. Ann N Y Acad Sci. 2001 May; 935:177-90. View Abstract
159. Limiting the location of putative human prostate cancer tumor suppressor genes on chromosome 18q. Oncogene. 2001 Apr 26; 20(18):2273-80. View Abstract
160. Genetic association analysis of behavioral inhibition using candidate loci from mouse models. Am J Med Genet. 2001 Apr 08; 105(3):226-35. View Abstract
161. Impact of tic disorders on ADHD outcome across the life cycle: findings from a large group of adults with and without ADHD. Am J Psychiatry. 2001 Apr; 158(4):611-7. View Abstract
162. A controlled study of behavioral inhibition in children of parents with panic disorder and depression. Am J Psychiatry. 2000 Dec; 157(12):2002-10. View Abstract
163. Identification of Icm protein complexes that play distinct roles in the biogenesis of an organelle permissive for Legionella pneumophila intracellular growth. Mol Microbiol. 2000 Nov; 38(4):719-36. View Abstract
164. Inactivation of MMAC1 in bladder transitional-cell carcinoma cell lines and specimens. Mol Carcinog. 2000 Nov; 29(3):143-50. View Abstract
165. Epidemiologic determinants of clinically relevant prostate cancer. Int J Cancer. 2000 May 20; 89(3):259-64. View Abstract
166. Limiting the location of a putative human prostate cancer tumor suppressor gene at chromosome 13q14.3. Oncogene. 1999 Dec 09; 18(52):7576-83. View Abstract
167. Adolescent social anxiety as an outcome of inhibited temperament in childhood. J Am Acad Child Adolesc Psychiatry. 1999 Aug; 38(8):1008-15. View Abstract
168. Startle potentiation by threat of aversive stimuli and darkness in adolescents: a multi-site study. Int J Psychophysiol. 1999 Apr; 32(1):63-73. View Abstract
169. Method to distinguish between the MMAC1/PTEN gene and its pseudogene in RT-PCR analysis of point mutations. Biotechniques. 1999 Jan; 26(1):19-22, 24. View Abstract
170. Localization of chromosome 8p regions involved in early tumorigenesis of oral and laryngeal squamous carcinoma. Oncogene. 1998 Jun 11; 16(23):2983-7. View Abstract
171. Cluster of allele losses within a 2.5 cM region of chromosome 10 in high-grade invasive bladder cancer. Oncogene. 1998 Feb 19; 16(7):909-13. View Abstract
172. Safety of autologous, ex vivo-expanded human immunodeficiency virus (HIV)-specific cytotoxic T-lymphocyte infusion in HIV-infected patients. Blood. 1997 Sep 15; 90(6):2196-206. View Abstract
173. Daylength during pregnancy and shyness in children: results from northern and southern hemispheres. Dev Psychobiol. 1997 Sep; 31(2):107-14. View Abstract
174. Influences of gender and social class on adolescents' perceptions of health. Arch Pediatr Adolesc Med. 1997 Sep; 151(9):899-904. View Abstract
175. Photochemical and photobiological studies of a furonaphthopyranone as a benzo-spaced psoralen analog in cell-free and cellular DNA. Photochem Photobiol. 1997 Jul; 66(1):46-54. View Abstract
176. Genotypic alterations in benign and malignant salivary gland tumors: histogenetic and clinical implications. Am J Surg Pathol. 1997 Jun; 21(6):691-7. View Abstract
177. An approach to the validation of markers for use in AIDS clinical trials. Clin Infect Dis. 1997 May; 24(5):764-74. View Abstract
178. Three-color supplement to the NIAID DAIDS guideline for flow cytometric immunophenotyping. Cytometry. 1996 Sep 15; 26(3):227-30. View Abstract
179. Perception of music by infants. Nature. 1996 Sep 05; 383(6595):29. View Abstract
180. A randomized, placebo-controlled study of the immunogenicity of human immunodeficiency virus (HIV) rgp160 vaccine in HIV-infected subjects with > or = 400/mm3 CD4 T lymphocytes (AIDS Clinical Trials Group Protocol 137). J Infect Dis. 1996 Jun; 173(6):1336-46. View Abstract
181. Homozygous deletions at 8p22 and 8p21 in prostate cancer implicate these regions as the sites for candidate tumor suppressor genes. Oncogene. 1995 Nov 16; 11(10):2121-6. View Abstract
182. Standardization of absolute CD4+ lymphocyte counts across laboratories: an evaluation of the Ortho CytoronAbsolute flow cytometry system on normal donors. Cytometry. 1995 Sep 15; 22(3):200-10. View Abstract
183. Interlaboratory variability of CD8 subset measurements by flow cytometry and its applications to multicenter clinical trials. NAID/NICHD Women and Infants Transmission Study Group. Clin Diagn Lab Immunol. 1995 Jul; 2(4):462-8. View Abstract
184. Joining of recombination signals on the der 14q- chromosome in T-cell acute leukemia with t(10;14) chromosome translocation. Cancer Res. 1994 Jan 01; 54(1):226-30. View Abstract
185. Guideline for flow cytometric immunophenotyping: a report from the National Institute of Allergy and Infectious Diseases, Division of AIDS. Cytometry. 1993 Oct; 14(7):702-15. View Abstract
186. A 3-year follow-up of children with and without behavioral inhibition. J Am Acad Child Adolesc Psychiatry. 1993 Jul; 32(4):814-21. View Abstract
187. Behavioral inhibition in childhood: a risk factor for anxiety disorders. Harv Rev Psychiatry. 1993 May-Jun; 1(1):2-16. View Abstract
188. The human urokinase-plasminogen activator gene (PLAU) is located on chromosome 10q24 centromeric to the HOX11 gene. Genomics. 1993 Apr; 16(1):301-2. View Abstract
189. NIAID Division of AIDS flow cytometry quality assessment program. Ann N Y Acad Sci. 1993 Mar 20; 677:50-2. View Abstract
190. Assessment of the effects of instrumentation, monoclonal antibody, and fluorochrome on flow cytometric immunophenotyping: a report based on 2 years of the NIAID DAIDS flow cytometry quality assessment program. Clin Immunol Immunopathol. 1993 Feb; 66(2):150-62. View Abstract
191. Advances in the diagnosis of acute leukemia. Hematol Oncol Clin North Am. 1993 Feb; 7(1):1-46. View Abstract
192. Molecular biology of chromosomal aberrations in leukemia/lymphoma. Hematol Pathol. 1993; 7(3):159-201. View Abstract
193. Comorbidity of parental anxiety disorders as risk for childhood-onset anxiety in inhibited children. Am J Psychiatry. 1992 Apr; 149(4):475-81. View Abstract
194. Stable behavioral inhibition and its association with anxiety disorder. J Am Acad Child Adolesc Psychiatry. 1992 Jan; 31(1):103-11. View Abstract
195. Molecular biology of lymphoid malignancies. Ann Oncol. 1991 Feb; 2 Suppl 2:9-21. View Abstract
196. Cloning and expression of the human substance K receptor and analysis of its role in mitogenesis. Cell Growth Differ. 1991 Jan; 2(1):15-22. View Abstract
197. Further evidence of an association between behavioral inhibition and anxiety disorders: results from a family study of children from a non-clinical sample. J Psychiatr Res. 1991; 25(1-2):49-65. View Abstract
198. Depression and allergies: survey of a nonclinical population. Psychother Psychosom. 1991; 55(1):24-31. View Abstract
199. Cloning, expression of the human substance K receptor, and analysis of its role in mitogenesis. Ann N Y Acad Sci. 1991; 632:426-7. View Abstract
200. The hemolysis of erythrocytes by singlet oxygen generated in the gas phase. Photochem Photobiol. 1990 Oct; 52(4):753-6. View Abstract
201. Detection of minimal residual disease in leukemic patients with the t(10;14)(q24;q11) chromosomal translocation. Cancer Res. 1990 Sep 01; 50(17):5240-4. View Abstract
202. Is allergic rhinitis more frequent in young adults with extreme shyness? A preliminary survey. Psychosom Med. 1990 Sep-Oct; 52(5):517-25. View Abstract
203. Expression and function of gamma delta- and alpha beta-T cell receptor heterodimers on human somatic T cell hybrids. J Immunol. 1990 May 15; 144(10):3677-83. View Abstract
204. Psychiatric correlates of behavioral inhibition in young children of parents with and without psychiatric disorders. Arch Gen Psychiatry. 1990 Jan; 47(1):21-6. View Abstract
205. Involvement of the TCL5 gene on human chromosome 1 in T-cell leukemia and melanoma. Proc Natl Acad Sci U S A. 1989 Jul; 86(13):5039-43. View Abstract
206. Clustering of breakpoints on chromosome 10 in acute T-cell leukemias with the t(10;14) chromosome translocation. Proc Natl Acad Sci U S A. 1989 Jun; 86(11):4161-5. View Abstract
207. The chromosome 11 region flanking the t(11;14) breakpoint in human T-ALL is deleted in Wilms' tumor hybrids. Oncogene Res. 1989; 5(2):143-8. View Abstract
208. Behavioral inhibition in children of parents with panic disorder and agoraphobia. A controlled study. Arch Gen Psychiatry. 1988 May; 45(5):463-70. View Abstract
209. Alpha-chain locus of the T-cell antigen receptor is involved in the t(10;14) chromosome translocation of T-cell acute lymphocytic leukemia. Proc Natl Acad Sci U S A. 1987 Jul; 84(13):4543-6. View Abstract
210. Carmichael's insight. Dev Psychobiol. 1987 May; 20(3):241-4. View Abstract
211. In vivo activity of affinity-purified helper factor from antigen-specific helper clone. J Immunol. 1985 Mar; 134(3):1717-22. View Abstract
212. In vitro selection of murine antigen-specific T-lymphocytes. I. Description of selection procedure. J Immunol Methods. 1981; 42(3):291-304. View Abstract
213. Antigen-induced proliferation of murine T-lymphocytes in vitro. II. The effect of different macrophage populations on the antigen-induced proliferative response. J Immunol Methods. 1981; 41(3):321-31. View Abstract
214. Antigen-induced proliferation of murine T-lymphocytes in vitro. I. Characterization of the lymphocyte culture system. J Immunol Methods. 1980; 37(1):15-27. View Abstract
Show All Publications Show Fewer Publications